FLA.Litigation
Florida sues Lilly, Novo Nordisk, Sanofi and three PBMs, alleging an insulin pricing scheme
Florida Attorney General James Uthmeier sued insulin makers Eli Lilly, Novo Nordisk and Sanofi, pharmacy benefit managers CVS Caremark, Express Scripts and OptumRx, and rebate aggregators Zinc, Ascent and Emisar in the Eleventh Judicial Circuit, his office announced September 22. The complaint alleges the manufacturers inflated list prices for insulin and related diabetes drugs while paying the PBMs rebates and fees for preferred formulary placement.
Filing (Florida Office of the Attorney General) → · WUSF, Bloomberg Law, Fierce Healthcare +1
Read the long piece on LexRegister
Key points
- The complaint brings two counts under the Florida Deceptive and Unfair Trade Practices Act and one under the Florida Antitrust Act.Florida Office of the Attorney General
- The state seeks a permanent injunction, restitution, disgorgement, damages, civil penalties and other relief.Florida Office of the Attorney General
- The suit also covers GLP-1 and combination products, including Ozempic, Trulicity, Victoza and Soliqua.Florida Office of the Attorney GeneralWUSF
- The release cites a Lilly executive's testimony that about $210 of every $280 Humalog vial goes to PBMs as rebates and discounts.Florida Office of the Attorney GeneralWUSF
- WUSF reported the case was filed in Miami-Dade County and also names UnitedHealthcare Insurance as a defendant.WUSF
Sources5 articles across 5 outlets
Bloomberg Law
Federal Trade Commission
Fierce Healthcare
Florida Office of the Attorney General
WUSF